Biogen is in deep trouble and may not survive
World of DTC Marketing
JULY 15, 2021
Biogen undertook a secret campaign, termed Project Onyx, to persuade FDA to approve Aduhelm. This approval was NOT about patients; it was about the profits of a pharma company in quicksand and sinking fast. That meeting was reportedly followed by a formal meeting between Biogen and FDA in June 2019.
Let's personalize your content